Daiichi moves Delhi HC to block sale of Fortis Healthcare to Manipal Hospital

Ashutosh Gambhir April 6 2018

The legal battle between Daiichi and former Ranbaxy promoters Malvinder and Shivinder Singh does not seem to be reaching an end. The Japanese drug maker has now approached the Delhi High Court to stop the sale of Fortis Healthcare to Manipal Health Enterprises.

The reason being Daiichi wants its Rs. 3,500 crore arbitration award to be paid by Singh brothers.

Daiichi-Sankyo had filed for the execution of the High Court's order, which had allowed 

With a premium account you get:
  • One year of unrestrcited access to previous interviews, columns and articles
  • One year access to all archival material
  • Access to all Bar & Bench reports